These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8488758)

  • 1. Laminin concentrations in serum and cerebrospinal fluid in aging and Alzheimer's disease.
    Kittur SD; Adler WH; Martin GR; Schapiro MB; Rapoport SI; Gunzler V
    Int J Dev Neurosci; 1993 Feb; 11(1):95-9. PubMed ID: 8488758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of laminins in the cerebrospinal fluid obtained from patients with Alzheimer's disease and vascular dementia using a modified enzyme-linked immunosorbent assay.
    Matsuda K; Tashiro K; Hayashi Y; Monji A; Yoshida I; Mitsuyama Y
    Dement Geriatr Cogn Disord; 2002; 14(3):113-22. PubMed ID: 12218253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients.
    Murtomäki S; Risteli J; Risteli L; Koivisto UM; Johansson S; Liesi P
    J Neurosci Res; 1992 Jun; 32(2):261-73. PubMed ID: 1404496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type.
    Yoshizawa T; Iwamoto H; Mizusawa H; Suzuki N; Matsumoto H; Kanazawa I
    Neuropeptides; 1992 Jun; 22(2):85-8. PubMed ID: 1407412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid.
    Swaab DF; Raadsheer FC; Endert E; Hofman MA; Kamphorst W; Ravid R
    J Neuroendocrinol; 1994 Dec; 6(6):681-7. PubMed ID: 7894471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between vascular basement membrane components and the lesions of Alzheimer's disease.
    Perlmutter LS; Barrón E; Saperia D; Chui HC
    J Neurosci Res; 1991 Dec; 30(4):673-81. PubMed ID: 1787541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
    Skoog I; Vanmechelen E; Andreasson LA; Palmertz B; Davidsson P; Hesse C; Blennow K
    Neurodegeneration; 1995 Dec; 4(4):433-42. PubMed ID: 8846237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.
    Harigaya Y; Shoji M; Nakamura T; Matsubara E; Hosoda K; Hirai S
    Intern Med; 1995 Jun; 34(6):481-4. PubMed ID: 7549128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agrin and microvascular damage in Alzheimer's disease.
    Berzin TM; Zipser BD; Rafii MS; Kuo-Leblanc V; Yancopoulos GD; Glass DJ; Fallon JR; Stopa EG
    Neurobiol Aging; 2000; 21(2):349-55. PubMed ID: 10867220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.
    Elovaara I; Palo J; Erkinjuntti T; Sulkava R
    Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
    J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cerebrospinal fluid tau in patients with Alzheimer's disease.
    Jensen M; Basun H; Lannfelt L
    Neurosci Lett; 1995 Feb; 186(2-3):189-91. PubMed ID: 7777193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease.
    Loeffler DA; Brickman CM; Juneau PL; Perry MF; Pomara N; Lewitt PA
    Neurobiol Aging; 1997; 18(5):555-7. PubMed ID: 9390784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease.
    Salehi Z; Mashayekhi F; Naji M
    Biofactors; 2008; 33(2):99-106. PubMed ID: 19346585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies.
    Slaets S; Le Bastard N; Theuns J; Sleegers K; Verstraeten A; De Leenheir E; Luyckx J; Martin JJ; Van Broeckhoven C; Engelborghs S
    J Alzheimers Dis; 2013; 35(1):137-46. PubMed ID: 23364139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.